Clinical Trials in Georgia

Showing 13021-13040 of 19,050 trials

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

NCT00446550

This study evaluated the safety and tolerability of afegostat tartrate in participants with type 1 Gaucher disease who were not receiving enzyme replacement therapy (ERT) or substrate reduction therapy (SRT).

Gaucher DiseaseType 1 Gaucher DiseaseGaucher Disease, Type 1

Amicus Therapeutics19 participantsStarted Jun 2008

Beverly Hills, California, United States • Coral Springs, Florida, United States • Decatur, Georgia, United States +8 more locations

COMPLETEDPhase 263 miles

A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients

NCT00813865

This study evaluated the long-term safety and efficacy of afegostat tartrate in participants with Gaucher disease who were enrolled in a previous Phase 2 study of afegostat tartrate.

Gaucher DiseaseType 1 Gaucher DiseaseGaucher Disease, Type 1

Amicus Therapeutics8 participantsStarted May 2009

Coral Springs, Florida, United States • Decatur, Georgia, United States • Boston, Massachusetts, United States +1 more locations

COMPLETEDPhase 265 miles

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

NCT00782626

The purpose of this research study is to learn if the study drug RAD001 can shrink or slow the growth of low-grade gliomas. Additionally, the safety of RAD001 will be studied. RAD001 is a drug that may act directly on tumor cells by inhibiting tumor cell growth and proliferation.

GliomaLow-grade GliomaAstrocytoma

Dana-Farber Cancer Institute23 participantsStarted Jun 2009

Phoenix, Arizona, United States • Denver, Colorado, United States • Gainesville, Florida, United States +7 more locations

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Find Trials by Condition in Georgia

Endothelial Hyperpolarization in Humans

S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps

SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis

Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease

Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

Clinical Assessment of a HYDRAGLYDE® Regimen

A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Predicting Acute Compartment Syndrome (PACS)

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment

Transfusion Requirements in Cardiac Surgery III

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients

Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer

Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma

A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)